🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate S1 capsule plus Cisplatin as adjuv...
Status
Unknown
Location
Jun Feng Liu
Start Date
2014-12
Trial ID
NCT02223611
Treatments Being Tested
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
Phase I part: to determine the recommended dose, and observe the preliminar...
Status
Completed
Location
Department of Oncology,National Taiwan University Hospital
Start Date
2008-11-24
Trial ID
NCT00912275
Treatments Being Tested
To evaluate the efficacy and safety of Linperlisib combined with standard i...
Status
Recruiting
Location
Institute of Hematology & Blood Disease Hospital
Start Date
2024-05-28
Trial ID
NCT06489808
The investigators hypothesize that the administration of Toripalimab (anti-...
Status
Unknown
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2020-04-01
Trial ID
NCT04389073
The goal of this observational study is to evaluate the efficacy and safety...
Status
Recruiting
Location
Anhui Chest Hosptial
Start Date
2023-06-15
Trial ID
NCT07041320
This is a phase II, multicenter, open-label, randomized controlled trial to...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-10-01
Trial ID
NCT06102824
This study aims to explore the efficacy of Disitamab vedotin in combination...
Status
Unknown
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06857747
Treatments Being Tested
This study will evaluate the toxicity and secondary the efficacy of the com...
Status
Completed
Location
University General Hospital of Alexandroupolis, Dept. of Medical Oncology
Start Date
2008-06
Trial ID
NCT00706069
Treatments Being Tested
* To identify the Maximum Tolerated Dose (MTD) of afatinib in combination w...
Status
Completed
Location
1200.84.003 Boehringer Ingelheim Investigational Site
Start Date
2010-10-01
Trial ID
NCT01214616
Treatments Being Tested